Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2023

Open Access 01-12-2023 | Hypersensitivity Pneumonitis | Research

Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis

Authors: Mohamed Abdelhakim Elnady, Reem Elkorashy, Afnan Nabil, Eman Kamal Ibrahim

Published in: BMC Pulmonary Medicine | Issue 1/2023

Login to get access

Abstract

Background

Hypersensitivity pneumonitis (HP) is an immunologically induced inflammation of the lung parenchyma that occurs in susceptible individuals in response to a variety of antigens. Repeated exposures to the causative antigens lead to chronic HP. The condition could be complicated with pulmonary hypertension (PH).

Methodology

60 patients with established diagnosis of HP were included, clinical examination, high resolution computed tomography (HRCT) of chest, arterial blood gases, six minute walking test (6MWT), desaturation index, spirometry, echocardiography were performed to all patients and right heart catheter was done for patients with high echo probability of PH.

Results

The mean age of patients was 41.67 ± 13.4 years with female predominance 83.3% of patients had history of raising birds. 71.7% of cases suffered from resting hypoxia with oxygen saturation 89 ± 11% with desaturation index 9% ± 8%, Echo probability of PH ranged from low to high 71.67, 21.67 and 6.67% respectively, mean pulmonary artery systolic pressure was 63.65 (18.48) mmHg. PH was diagnosed in 17 (28.33%) patients. HP with PH patients were significantly more symptomatic with predominant fibrotic pattern in HRCT chest P < 0.001, 82% of them had hypoxia P < 0.001 with significant desaturation after 6MWT P = 0.001. Predictors of PH in study group were fibrotic pattern in HRCT chest and hypoxia OR = 62.22, P < 0.001; 49.2, P < 0.001 respectively.

Conclusion

PH was prevalent in 28.33% of patients with HP, predictors of development of PH were fibrotic pattern in HRCT chest and hypoxia.
Trial registration: Retrospectively registered, registration number is NCT05458635, date of registration 07/12/2022.
Appendix
Available only for authorised users
Literature
1.
go back to reference Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med. 2012;33(1):151–63.CrossRefPubMed Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med. 2012;33(1):151–63.CrossRefPubMed
2.
go back to reference El-Kareem A, Akl YM, Nakhla GA, Elhindawi AA, Eltorky MA. Clinico-pathologic presentation of hypersensitivity pneumonitis in Egyptian patients: a multidisciplinary study. Multidiscip Respir Med. 2017;12(1):1–9. El-Kareem A, Akl YM, Nakhla GA, Elhindawi AA, Eltorky MA. Clinico-pathologic presentation of hypersensitivity pneumonitis in Egyptian patients: a multidisciplinary study. Multidiscip Respir Med. 2017;12(1):1–9.
3.
go back to reference Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69.CrossRefPubMedPubMedCentral Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69.CrossRefPubMedPubMedCentral
4.
go back to reference Dybowska M, Barańska I, Franczuk M, Skoczylas A, Szturmowicz M. Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors. J Thorac Dis. 2021;13(7):3988.CrossRefPubMedPubMedCentral Dybowska M, Barańska I, Franczuk M, Skoczylas A, Szturmowicz M. Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors. J Thorac Dis. 2021;13(7):3988.CrossRefPubMedPubMedCentral
5.
go back to reference Dias OM, Baldi BG, Ferreira JG, Cardenas LZ, Pennati F, Salito C, Carvalho CR, Aliverti A, de Albuquerque AL. Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis. ERJ Open Res. 2018;4(3). Dias OM, Baldi BG, Ferreira JG, Cardenas LZ, Pennati F, Salito C, Carvalho CR, Aliverti A, de Albuquerque AL. Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis. ERJ Open Res. 2018;4(3).
6.
go back to reference King CS, Nathan SD. Pulmonary hypertension due to interstitial lung disease. Curr Opin Pulm Med. 2019;25(5):459–67.CrossRefPubMed King CS, Nathan SD. Pulmonary hypertension due to interstitial lung disease. Curr Opin Pulm Med. 2019;25(5):459–67.CrossRefPubMed
10.
go back to reference Rival G, Manzoni P, Lacasse Y, Polio JC, Westeel V, Dubiez A, Soumagne T, Laurent F, Dalphin JC. High-resolution CT predictors of hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(2):117–23.PubMed Rival G, Manzoni P, Lacasse Y, Polio JC, Westeel V, Dubiez A, Soumagne T, Laurent F, Dalphin JC. High-resolution CT predictors of hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(2):117–23.PubMed
12.
go back to reference Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Beghetti M, Ghofrani A. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Revista Espanola de Cardiologia (Engl ed). 2016;69(2):177. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Beghetti M, Ghofrani A. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Revista Espanola de Cardiologia (Engl ed). 2016;69(2):177.
13.
go back to reference Akl Y, Soliman Y, El-Korashy R, El-Hennawi Y. Demographic study of hypersensitivity pneumonitis in egypt: a single center experience. Am J Respir Crit Care Med. 2017;195:A1566. Akl Y, Soliman Y, El-Korashy R, El-Hennawi Y. Demographic study of hypersensitivity pneumonitis in egypt: a single center experience. Am J Respir Crit Care Med. 2017;195:A1566.
16.
go back to reference Jacobsen G, Schlunssen V, Schaumburg I, Sigsgaard T. Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood. Eur Respir J. 2009;33(6):1268–76.CrossRefPubMed Jacobsen G, Schlunssen V, Schaumburg I, Sigsgaard T. Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood. Eur Respir J. 2009;33(6):1268–76.CrossRefPubMed
22.
go back to reference Chung JH, et al. Presence of air trapping and mosaic attenuation on chest computed tomography predicts survival in chronic hypersensitivity pneumonitis. Ann Am Thorac Soc. 2017;14(10):1533–8.CrossRefPubMed Chung JH, et al. Presence of air trapping and mosaic attenuation on chest computed tomography predicts survival in chronic hypersensitivity pneumonitis. Ann Am Thorac Soc. 2017;14(10):1533–8.CrossRefPubMed
24.
go back to reference El-Korashy RI. Exercise desaturation as a marker of disease severity in pulmonary arterial hypertension. Egypt J Chest Dis Tuberc. 2019;68:412–5. El-Korashy RI. Exercise desaturation as a marker of disease severity in pulmonary arterial hypertension. Egypt J Chest Dis Tuberc. 2019;68:412–5.
Metadata
Title
Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis
Authors
Mohamed Abdelhakim Elnady
Reem Elkorashy
Afnan Nabil
Eman Kamal Ibrahim
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2023
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-023-02347-1

Other articles of this Issue 1/2023

BMC Pulmonary Medicine 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.